Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Sulotroban
Cat. No.:
0225LY-0924
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Sulotroban is a TXA2 receptor antagonist that works in synergy with iloprost to suppress platelet activation dependent on TXA2.
Synonym:
72131-33-0; BM-13177; BM 13.177; BM 13177; SK&F-95587; 2-[4-[2-(benzenesulfonamido)ethyl]phenoxy]acetic acid; Acetic acid, (4-(2-((phenylsulfonyl)amino)ethyl)phenoxy)-; (p-(2-Benzenesulfonamidoethyl)phenoxy)acetic acid; 4-(2-(benzenesulfonamido)ethyl)phenoxyacetic acid; (4-(2-((Phenylsulfonyl)amino)ethyl)phenoxy)acetic acid
CAS No.:
72131-33-0
Compound CID:
51550
Formula:
C16H17NO5S
Formula Weight:
335.37
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Sulotroban can be used in thrombosis research to investigate the inhibition of thromboxane-induced platelet activation.
Library Information
Target:
TXAS
Receptor:
TXA2R
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
h5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 149.09 mM
